SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Agencies, foundations and societies at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
19 agencies, foundations and societies are at SNO 2026 — 59 presentations on the program. Most represented: National Cancer Institute (12 on the program), National Institutes of Health (7 on the program), National Brain Tumor Society (4 on the program). 1 of them have their own page in this guide. As of Nov 12, 2026.
Topic
Top represented
Showing 1–8 of 19 organizations
| Organization | SNO 2026 Attendance |
|---|---|
National Cancer Institute Bethesda, MD | |
A U.S. federal institute that supports cancer research and provides information on cancer prevention, diagnosis, and treatment. | Plenary Fri Nov 13 9:50–10am Talk Fri Nov 13 12:15–12:18pm Talk Fri Nov 13 12:27–12:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 11:39–11:42am Talk Sat Nov 14 12:15–12:18pm |
National Institutes of Health Bethesda, MD | |
The U.S. government’s medical research agency, supporting biomedical research including cancer and brain tumor studies. | Talk Thu Nov 12 11:05am–1:50pm Talk Fri Nov 13 12:12–12:15pm Talk Fri Nov 13 12:18–12:21pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 2:30–3:30pm |
National Brain Tumor Society Newton, MA | ◆Platinum Supporter |
A nonprofit that funds brain tumor research and advocates for people affected by brain tumors. | Session Thu Nov 12 11:05am–1:50pm Talk Thu Nov 12 4:30–5:35pm Session Thu Nov 12 4:30–5:35pm Poster Fri Nov 13 7:30–9:30pm |
Society for Neuro-Oncology Houston, TX | |
A professional society advancing neuro-oncology research, education, and care. | Talk Thu Nov 12 2–3:30pm Session Fri Nov 13 8:30–10am Session Sat Nov 14 8:30–10am |
A nonprofit research organization that collects and shares epidemiologic data on brain and central nervous system tumors to support research and public health. | Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm |
Immune Oncology Research Institute Yerevan, Armenia | |
A nonprofit research and educational institute advancing cancer research, clinical innovation, and access to oncology therapies. | Poster Fri Nov 13 7:30–9:30pm |
National Cancer Center Japan Kashiwa, Japan | |
A National Cancer Center unit that supports early-stage oncology research and clinical trials. | Talk Fri Nov 13 5:14–5:21pm |
TF Tough2gether Foundation Manhattan, KS | |
A nonprofit supporting families affected by diffuse midline glioma through education, resources, and research. | Poster Fri Nov 13 7:30–9:30pm |
Find buyers from agencies, foundations and societies
Tell us what you sell and we’ll find the people at these agencies, foundations and societies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SNO 2026 by
Organization type
Topic
- Tumor biology: signaling, metabolism, stem cells and the tumor microenvironment 106
- Cancer neuroscience: how neurons and brain tumors interact 54
- Immunobiology, immunotherapy and cell therapies 64
- Experimental therapeutics, drug discovery and resistance, drug delivery and tumor models 105
- Clinical trials, trial design and trials in progress 99
- Molecular pathology, tumor classification and (epi)genomics 102
- Biomarkers and liquid biopsy 53
- Neuroimaging, PET and response assessment 62
- Neurosurgery and surgical therapies 41
- Radiotherapy, radiobiology and radiopharmaceuticals 49
- Pediatric and adolescent and young adult (AYA) brain tumors 55
- Brain and leptomeningeal metastases 27
- Rare CNS tumors and tumor predisposition syndromes 34
- CNS lymphoma and neurohematology 13
- Survivorship, quality of life, cognition, neurologic complications and palliative care 105
- Health disparities, epidemiology and quality improvement 58
Everyone
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction